









Markets
/
Stocks
/
nasdaq-tdoc
/

Teladoc Health Inc

TDOC

8.200USD

+0.040+0.49%

Close 09/29, 16:00（ET）Quotes delayed by 15 min

1.45BMarket Cap

LossP/E TTM



Teladoc Health Inc

8.200

+0.040+0.49%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Teladoc Health Inc

Currency: USD Updated: 2025-09-29

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a good stock market performance and outperforming fundamentals, the technicals don't support the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Teladoc Health Inc's Score

Industry at a Glance

Industry Ranking

41 / 72

Overall Ranking

198 / 4714

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 26 analysts

Hold

Current Rating

9.025

Target Price

+10.60%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Teladoc Health Inc Highlights

StrengthsRisks

Teladoc Health, Inc. provides virtual healthcare services. The Company operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. The Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed primarily on a business-to-business (B2B) basis. The BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 40,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs.

Undervalued

The company’s latest PE is -7.15, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 134.63M shares, decreasing 23.79% quarter-over-quarter.

Held by Steven Cohen

Star Investor Steven Cohen holds 7.84M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.02.

Financial Health

Currency: USD Updated: 2025-09-29

The company's current financial score is 7.10, which is lower than the Healthcare Providers & Services industry's average of 7.27. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 631.90M, representing a year-over-year decrease of 1.64%, while its net profit experienced a year-over-year decrease of 96.10%.

Score

Industry at a Glance

Previous score

7.10

Change



Financials

7.78

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

4.01

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

6.48

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.23

Key Metrics

Free cash flow

No Data

Teladoc Health Inc's Company Valuation

Currency: USD Updated: 2025-09-29

The company’s current valuation score is 8.91, which is higher than the Healthcare Providers & Services industry's average of 7.12. Its current P/E ratio is -7.15, which is -96.32% below the recent high of -0.26 and -130.00% above the recent low of -16.45.

Score

Industry at a Glance

Previous score

8.91

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 41/72

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-29

The company’s current earnings forecast score is 6.44, which is lower than the Healthcare Providers & Services industry's average of 7.58. The average price target for Teladoc Health Inc is 8.25, with a high of 12.00 and a low of 7.00.

Score

Industry at a Glance

Previous score

6.44

Change

Support & Resistance

No Data

Analyst Rating

Based on 26 analysts

Hold

Current Rating

9.025

Target Price

+10.60%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Teladoc Health Inc

TDOC

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Tenet Healthcare Corp

THC

Natera Inc

NTRA

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-29

The company’s current price momentum score is 5.83, which is lower than the Healthcare Providers & Services industry's average of 7.49. Sideways: Currently, the stock price is trading between the resistance level at 8.92 and the support level at 7.47, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

5.27

Change

0.56

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.047

Buy

RSI(14)

56.687

Neutral

STOCH(KDJ)(9,3,3)

41.261

Neutral

ATR(14)

0.382

High Vlolatility

CCI(14)

64.856

Neutral

Williams %R

48.951

Neutral

TRIX(12,20)

0.345

Sell

StochRSI(14)

41.495

Buy

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

8.216

Sell

MA10

8.125

Buy

MA20

7.917

Buy

MA50

7.677

Buy

MA100

7.613

Buy

MA200

8.472

Sell

Institutional Confidence

Currency: USD Updated: 2025-09-29

The company’s current institutional recognition score is 7.00, which is lower than the Healthcare Providers & Services industry's average of 8.03. The latest institutional shareholding proportion is 76.20%, representing a quarter-over-quarter increase of 0.94%. The largest institutional shareholder is The Vanguard, holding a total of 20.91M shares, representing 11.83% of shares outstanding, with 11.33% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

19.64M

+6.57%

BlackRock Institutional Trust Company, N.A.

12.78M

-6.56%

Point72 Asset Management, L.P.

Star Investors

6.51M

-41.77%

Renaissance Technologies LLC

Star Investors

6.55M

+15.36%

Dimensional Fund Advisors, L.P.

5.05M

+43.03%

Two Sigma Investments, LP

5.30M

+23.96%

State Street Global Advisors (US)

5.01M

-1.30%

Geode Capital Management, L.L.C.

4.07M

+2.99%

Wellington Management Company, LLP

2.59M

-17.40%

Maple Rock Capital Partners, Inc.

3.35M

-6.00%

Risk Assessment

Currency: USD Updated: 2025-09-29

The company’s current risk assessment score is 5.69, which is higher than the Healthcare Providers & Services industry's average of 5.30. The company's beta value is 1.92. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.